# Biotech Daily Digest — 2025-10-02

**47 items from 3 sources**

## Summary by Source

- Endpoints News: 10 items
- Fierce Biotech: 8 items
- arXiv q-bio: 29 items


## Endpoints News

- **[Biotech IPOs in Hong Kong far outpace the US driven by China’s buzzy biotech sector](https://endpoints.news/biotech-ipos-in-hong-kong-far-outpace-the-us-driven-by-chinas-buzzy-biotech-sector/)**  
  _Thu, 02 Oct 2025 14:39:04 +0000_  
  As biotech IPOs hit a record low in the US, more than 40 Chinese biopharma companies have filed to go public so far this year. That’s more than four times the number that have sought ...

- **[Amgen’s cholesterol-lowering shot could get sales boost from CV trial success](https://endpoints.news/amgens-cholesterol-lowering-shot-could-get-sales-boost-from-cv-trial-success/)**  
  _Thu, 02 Oct 2025 13:00:40 +0000_  
  Amgen’s cholesterol-cutting drug Repatha can reduce the risk of events like heart attack and stroke in high-risk patients who have not had one of these issues before, according to new data from a large trial ...

- **[Roche was the only pharma to make an acquisition offer for 89bio](https://endpoints.news/roche-was-the-only-pharma-to-make-an-acquisition-offer-for-89bio/)**  
  _Thu, 02 Oct 2025 12:41:57 +0000_  
  Roche's $2.4 billion deal for 89bio last month came after a series of increased acquisition offers, a deep dive into the MASH biotech's third-party manufacturers, and ...

- **[A year after collaborating with Gilead, Cartography maps out its own Phase 1 with $67M Series B](https://endpoints.news/a-year-after-collaborating-with-gilead-cartography-maps-out-its-own-phase-1-with-67m-series-b/)**  
  _Thu, 02 Oct 2025 11:30:35 +0000_  
  Pfizer and Amgen's corporate venture arms are jumping into T cell engagers by investing in Cartography Biosciences' $67 million Series B.

 The Bay Area startup, which is developing bispecific and multispecific antibodies for cancer patients ...

- **[Takeda lays off 137 workers following cell therapy stoppage](https://endpoints.news/takeda-lays-off-137-workers-following-cell-therapy-stoppage/)**  
  _Thu, 02 Oct 2025 08:54:55 +0000_  
  Takeda is laying off 137 employees in Massachusetts as a result of its decision to stop work in cell therapy, a spokesperson confirmed to Endpoints News. The move comes as the company has been paring ...

- **[Galapagos says it’s weeks away from decision on cell therapy business review](https://endpoints.news/galapagos-says-its-weeks-away-from-decision-on-cell-therapy-business-review/)**  
  _Thu, 02 Oct 2025 01:59:11 +0000_  
  After making cell therapy the thrust of its attempted turnaround effort, Galapagos said in May it would seek strategic alternatives instead for that business and create a new pipeline.

 On Wednesday, the storied Belgian drug ...

- **[Third-round IRA guidance spells out new orphan drug protections](https://endpoints.news/third-round-ira-guidance-spells-out-new-orphan-drug-protections/)**  
  _Wed, 01 Oct 2025 20:00:21 +0000_  
  CMS finalized guidance this week that the agency says will increase transparency in the third round of Medicare drug price negotiations and “preserve critical incentives for rare disease research.”

 The guidance sets requirements for the ...

- **[Pfizer-White House deal prompts pharma rally on Wall Street](https://endpoints.news/pfizer-white-house-deal-prompts-pharma-rally-on-wall-street/)**  
  _Wed, 01 Oct 2025 19:48:48 +0000_  
  Of all the obstacles that the pharmaceutical industry has faced in the first year of President Donald Trump’s second term, none have struck more fear in executives, board rooms and investors than the president’s push ...

- **[Biogen owes Genentech $88M in royalties from Tysabri, court rules](https://endpoints.news/biogen-owes-genentech-88m-in-royalties-from-tysabri-court-rules/)**  
  _Wed, 01 Oct 2025 19:24:10 +0000_  
  Biogen should pay Genentech more than $88 million in additional royalties for using Genentech’s patented process to help make the monoclonal antibody Tysabri, a California federal judge ruled.

 The case centers on an agreement from ...

- **[Takeda stops all work in cell therapy](https://endpoints.news/takeda-stops-all-work-in-cell-therapy/)**  
  _Wed, 01 Oct 2025 15:04:44 +0000_  
  Takeda is discontinuing its cell therapy efforts after it already pared back its work in the field.

 It’s another blow to a cell therapy industry that has fallen out of favor as companies struggled to ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/biotech/fierce-biotech-layoff-tracker-2025" hreflang="en">Fierce Biotech Layoff Tracker 2025: Bolt halves headcount; Sutro loses third of workforce</a>](https://www.fiercebiotech.com/biotech/fierce-biotech-layoff-tracker-2025)**  
  _Dec 23, 2024 11:52am_  
  As always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial team.

- **[<a href="https://www.fiercebiotech.com/biotech/after-courting-14-pharmas-89bio-was-left-between-roche-and-hard-place-buyout-talks" hreflang="en">After courting 14 pharmas, 89bio was left between a Roche and hard place in buyout talks</a>](https://www.fiercebiotech.com/biotech/after-courting-14-pharmas-89bio-was-left-between-roche-and-hard-place-buyout-talks)**  
  _Oct 2, 2025 9:19am_  
  89bio has set out the journey that led it from talks with a long list of drugmakers to weeks of negotiations with Roche to iron out the details of a deal worth up to $3.5 billion.

- **[<a href="https://www.fiercebiotech.com/biotech/singapore-drug-discovery-platform-heads-nasdaq-spac-deal" hreflang="en">Singapore drug discovery platform heads to Nasdaq via SPAC deal</a>](https://www.fiercebiotech.com/biotech/singapore-drug-discovery-platform-heads-nasdaq-spac-deal)**  
  _Oct 2, 2025 9:23am_  
  An AI-driven drug discovery platform will receive a step up onto the Nasdaq via a reverse merger with a blank check company.

- **[<a href="https://www.fiercebiotech.com/biotech/bolt-halves-workforce-again-find-cash-fund-immunotherapy-readout" hreflang="en">Bolt halves workforce (again) to find cash to fund immunotherapy readout</a>](https://www.fiercebiotech.com/biotech/bolt-halves-workforce-again-find-cash-fund-immunotherapy-readout)**  
  _Oct 2, 2025 4:33am_  
  Bolt Biotherapeutics has halved its workforce for the second time in two years as the oncology biotech delays a readout of its lead immunotherapy.

- **[<a href="https://www.fiercebiotech.com/biotech/takeda-taps-out-cell-therapy-arena-part-strategic-shift" hreflang="en">UPDATED: Takeda lays off 137 US staff as part of retreat from cell therapy</a>](https://www.fiercebiotech.com/biotech/takeda-taps-out-cell-therapy-arena-part-strategic-shift)**  
  _Oct 1, 2025 2:13pm_  
  Takeda is tapping out of the cell therapy arena as part of a strategic portfolio reprioritization, the Japanese drugmaker announced on Oct. 1, becoming the latest Big Pharma to back away from the modality.

- **[<a href="https://www.fiercebiotech.com/pharma/halozyme-buys-subcutaneous-drug-delivery-peer-elektrofi-900m" hreflang="en">Halozyme buys subcutaneous drug delivery peer Elektrofi for up to $900M</a>](https://www.fiercebiotech.com/pharma/halozyme-buys-subcutaneous-drug-delivery-peer-elektrofi-900m)**  
  _Oct 1, 2025 2:11pm_  
  In a merger between two subcutaneous drug delivery companies, Halozyme Therapeutics is paying $750 million in cash to acquire Elektrofi.

- **[<a href="https://www.fiercebiotech.com/research/nih-research-grinds-halt-government-shuts-down" hreflang="en">NIH research grinds to a halt as government shuts down</a>](https://www.fiercebiotech.com/research/nih-research-grinds-halt-government-shuts-down)**  
  _Oct 1, 2025 10:52am_  
  As the U.S. government shuts down due to a failure of Congress to pass a spending bill, the National Institutes of Health is implementing a contingency staffing plan that will again roil a research apparatus that has already been heavily disrupted during the second Trump administration.

- **[<a href="https://www.fiercebiotech.com/medtech/illumina-launches-ai-informatics-business-multi-omic-drug-discovery" hreflang="en">Illumina launches AI informatics business for multi-omic drug discovery</a>](https://www.fiercebiotech.com/medtech/illumina-launches-ai-informatics-business-multi-omic-drug-discovery)**  
  _Oct 1, 2025 11:19am_  
  The BioInsight division plans to connect with population-wide, multimodal studies, including national initiatives and strategic partnerships with the biopharma industry.


## arXiv q-bio

- **[Robust State-space Reconstruction of Brain Dynamics via Bootstrap Monte Carlo SSA](https://arxiv.org/abs/2510.00011)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2510.00011v1 Announce Type: new 
Abstract: Reconstructing latent state-space geometry from time series provides a powerful route to studying nonlinear dynamics across complex systems. Delay-coordinate embedding provides the theoretical basis but assumes long, noise-free recordings, which many domains violate. In…

- **[Behavioural Classification in C. elegans: a Spatio-Temporal Analysis of Locomotion](https://arxiv.org/abs/2510.00086)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2510.00086v1 Announce Type: new 
Abstract: The 1mm roundworm C. elegans is a model organism used in many sub-areas of biology to investigate different types of biological processes. In order to complement the n-vivo analysis with computer-based investigations, several methods have been proposed to simulate the w…

- **[Information and the living tree of life: A theory of measurement grounded in biology](https://arxiv.org/abs/2510.00155)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2510.00155v1 Announce Type: new 
Abstract: We extend a formal framework that previously derived time from the multifractal structure of biological lineages (Hudnall \& D'Souza, 2025). That work showed that time itself is multifractal -- not a universal background dimension, but an observer-dependent geometry. He…

- **[Identification of post-COVID-19 symptoms using brain structural MRI features: a machine learning approach](https://arxiv.org/abs/2510.00195)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2510.00195v1 Announce Type: new 
Abstract: Identifying long COVID symptoms is a challenging task, primarily due to the reliance on patient reports and the lack of disease specific biomarkers. The objective of this study is to identify individual long COVID symptoms, post COVID 19 conditions (PCC) participants, a…

- **[Modelling road mortality risks to persistence to a Western Toad ({\it Anaxyrus boreas}) population in British Columbia](https://arxiv.org/abs/2510.00340)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2510.00340v1 Announce Type: new 
Abstract: Road mortality may be a significant factor in the global decline of amphibian populations, yet rigorous assessments of its effect on long-term population persistence are lacking.
  Here, we investigate population persistence through a field study and mathematical model…

- **[A Deep Learning Pipeline for Epilepsy Genomic Analysis Using GPT-2 XL and NVIDIA H100](https://arxiv.org/abs/2510.00392)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2510.00392v1 Announce Type: new 
Abstract: Epilepsy is a chronic neurological condition characterized by recurrent seizures, with global prevalence estimated at 50 million people worldwide. While progress in high-throughput sequencing has allowed for broad-based transcriptomic profiling of brain tissues, the dec…

- **[Evolutionary Kuramoto dynamics unravels origins of chimera states in neural populations](https://arxiv.org/abs/2510.00423)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2510.00423v1 Announce Type: new 
Abstract: Neural synchronization is central to cognition However, incomplete synchronization often produces chimera states where coherent and incoherent dynamics coexist. While previous studies have explored such patterns using networks of coupled oscillators, it remains unclear…

- **[Emergence of robust looming selectivity via coordinated inhibitory neural computations](https://arxiv.org/abs/2510.00498)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2510.00498v1 Announce Type: new 
Abstract: In the locust's lobula giant movement detector neural pathways, four categories of inhibition, i.e., global inhibition, self-inhibition, lateral inhibition, and feed-forward inhibition, have been functionally explored in the context of looming perception. However, their…

- **[Adaptive Data-Knowledge Alignment in Genetic Perturbation Prediction](https://arxiv.org/abs/2510.00512)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2510.00512v1 Announce Type: new 
Abstract: The transcriptional response to genetic perturbation reveals fundamental insights into complex cellular systems. While current approaches have made progress in predicting genetic perturbation responses, they provide limited biological understanding and cannot systematic…

- **[Emergence of Deviance Detection in Cortical Cultures through Maturation, Criticality, and Early Experience](https://arxiv.org/abs/2510.00764)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2510.00764v1 Announce Type: new 
Abstract: Mismatch negativity (MMN) in humans reflects deviance detection (DD), a core neural mechanism of predictive processing. However, the fundamental principles by which DD emerges and matures during early cortical development-potentially providing a neuronal scaffold for MM…

- **[Some Further Developments on a Neurobiologically-based Model for Color Sensations in Humans](https://arxiv.org/abs/2510.01000)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2510.01000v1 Announce Type: new 
Abstract: At HVEI-2012, I presented a neurobiologically-based model for trichromatic color sensations in humans, mapping the neural substrate for color sensations to V1-L4: the thalamic recipient layer of the primary visual cortex. In this paper, I propose that V1-L4 itself consi…

- **[Evaluating sampling strategies for effective detection of African swine fever in the growing pig population in the U.S](https://arxiv.org/abs/2510.01026)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2510.01026v1 Announce Type: new 
Abstract: Early detection of African swine fever virus (ASFV) is critical to preventing widespread epidemics. However, the effectiveness of within-farm sampling remains to be examined, particularly during the early phase of an outbreak when disease prevalence is low, animals may…

- **[Integrative modelling of biomolecular dynamics](https://arxiv.org/abs/2510.01108)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2510.01108v1 Announce Type: new 
Abstract: Much of our mechanistic understanding of the functions of biological macromolecules is based on static structural experiments, which can be modelled either as single structures or conformational ensembles. While these provide us with invaluable insights, they do not dir…

- **[Learning Inter-Atomic Potentials without Explicit Equivariance](https://arxiv.org/abs/2510.00027)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2510.00027v1 Announce Type: cross 
Abstract: Accurate and scalable machine-learned inter-atomic potentials (MLIPs) are essential for molecular simulations ranging from drug discovery to new material design. Current state-of-the-art models enforce roto-translational symmetries through equivariant neural network a…

- **[WaveMind: Towards a Conversational EEG Foundation Model Aligned to Textual and Visual Modalities](https://arxiv.org/abs/2510.00032)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2510.00032v1 Announce Type: cross 
Abstract: Electroencephalography (EEG) interpretation using multimodal large language models (MLLMs) offers a novel approach for analyzing brain signals. However, the complex nature of brain activity introduces critical challenges: EEG signals simultaneously encode both cogniti…

- **[Latent Representation Learning from 3D Brain MRI for Interpretable Prediction in Multiple Sclerosis](https://arxiv.org/abs/2510.00051)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2510.00051v1 Announce Type: cross 
Abstract: We present InfoVAE-Med3D, a latent-representation learning approach for 3D brain MRI that targets interpretable biomarkers of cognitive decline. Standard statistical models and shallow machine learning often lack power, while most deep learning methods behave as black…

- **[Revealing the temporal dynamics of antibiotic anomalies in the infant gut microbiome with neural jump ODEs](https://arxiv.org/abs/2510.00087)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2510.00087v1 Announce Type: cross 
Abstract: Detecting anomalies in irregularly sampled multi-variate time-series is challenging, especially in data-scarce settings. Here we introduce an anomaly detection framework for irregularly sampled time-series that leverages neural jump ordinary differential equations (NJ…

- **[Flow Autoencoders are Effective Protein Tokenizers](https://arxiv.org/abs/2510.00351)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2510.00351v1 Announce Type: cross 
Abstract: Protein structure tokenizers enable the creation of multimodal models of protein structure, sequence, and function. Current approaches to protein structure tokenization rely on bespoke components that are invariant to spatial symmetries, but that are challenging to op…

- **[AReUReDi: Annealed Rectified Updates for Refining Discrete Flows with Multi-Objective Guidance](https://arxiv.org/abs/2510.00352)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2510.00352v1 Announce Type: cross 
Abstract: Designing sequences that satisfy multiple, often conflicting, objectives is a central challenge in therapeutic and biomolecular engineering. Existing generative frameworks largely operate in continuous spaces with single-objective guidance, while discrete approaches l…

- **[Neural Diffusion Processes for Physically Interpretable Survival Prediction](https://arxiv.org/abs/2510.00733)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2510.00733v1 Announce Type: cross 
Abstract: We introduce DeepFHT, a survival-analysis framework that couples deep neural networks with first hitting time (FHT) distributions from stochastic process theory. Time to event is represented as the first passage of a latent diffusion process to an absorbing boundary.…

- **[Adaptive Federated Few-Shot Rare-Disease Diagnosis with Energy-Aware Secure Aggregation](https://arxiv.org/abs/2510.00976)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2510.00976v1 Announce Type: cross 
Abstract: Rare-disease diagnosis remains one of the most pressing challenges in digital health, hindered by extreme data scarcity, privacy concerns, and the limited resources of edge devices. This paper proposes the Adaptive Federated Few-Shot Rare-Disease Diagnosis (AFFR) fram…

- **[Parameter Estimation in Recurrent Tumor Evolution with Finite Carrying Capacity](https://arxiv.org/abs/2510.01078)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2510.01078v1 Announce Type: cross 
Abstract: In this work, we investigate the population dynamics of tumor cells under therapeutic pressure. Although drug treatment initially induces a reduction in tumor burden, treatment failure frequently occurs over time due to the emergence of drug resistance, ultimately lea…

- **[Integration of Calcium Imaging Traces via Deep Generative Modeling](https://arxiv.org/abs/2501.14615)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2501.14615v3 Announce Type: replace 
Abstract: Calcium imaging allows for the parallel measurement of large neuronal populations in a spatially resolved and minimally invasive manner, and has become a gold-standard for neuronal functionality. While deep generative models have been successfully applied to study t…

- **[The influence of cell phenotype on collective cell invasion into the extracellular matrix](https://arxiv.org/abs/2506.06810)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2506.06810v2 Announce Type: replace 
Abstract: Understanding the interactions between cells and the extracellular matrix (ECM) during collective cell invasion is crucial for advancements in tissue engineering, cancer therapies, and regenerative medicine. This study focuses on the roles of contact guidance and EC…

- **[Achieving More Human Brain-Like Vision via Human EEG Representational Alignment](https://arxiv.org/abs/2401.17231)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2401.17231v3 Announce Type: replace-cross 
Abstract: Despite advancements in artificial intelligence, object recognition models still lag behind in emulating visual information processing in human brains. Recent studies have highlighted the potential of using neural data to mimic brain processing; however, these…

- **[PhyloLM : Inferring the Phylogeny of Large Language Models and Predicting their Performances in Benchmarks](https://arxiv.org/abs/2404.04671)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2404.04671v4 Announce Type: replace-cross 
Abstract: This paper introduces PhyloLM, a method adapting phylogenetic algorithms to Large Language Models (LLMs) to explore whether and how they relate to each other and to predict their performance characteristics. Our method calculates a phylogenetic distance metric…

- **[From reductionism to realism: Holistic mathematical modelling for complex biological systems](https://arxiv.org/abs/2503.20511)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2503.20511v2 Announce Type: replace-cross 
Abstract: At its core, the physics paradigm adopts a reductionist approach, aiming to understand fundamental phenomena by decomposing them into simpler, elementary processes. While this strategy has been tremendously successful in physics, it has often fallen short in a…

- **[The Rhythm of Aging: Stability and Drift in Human Senescence](https://arxiv.org/abs/2504.04143)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2504.04143v3 Announce Type: replace-cross 
Abstract: Human aging is marked by a steady rise in the risk of dying with age--a process demographers call senescence. Over the past century, life expectancy has risen dramatically, but is this because we are aging slower, or simply starting it later? Vaupel hypothesiz…

- **[Estimating Visceral Adiposity from Wrist-Worn Accelerometry](https://arxiv.org/abs/2506.09167)**  
  _Thu, 02 Oct 2025 00:00:00 -0400_  
  arXiv:2506.09167v2 Announce Type: replace-cross 
Abstract: Visceral adipose tissue (VAT) is a key marker of both metabolic health and habitual physical activity (PA). Excess VAT is highly correlated with type 2 diabetes and insulin resistance. The mechanistic basis for this pathophysiology relates to overloading the l…
